Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

Conditions

• Aplastic Anemia

Interventions

• BIOLOGICAL: Allogeneic hematopoietic stem cell transplantation Stem cell source only Bone Marrow

Sponsor

Assistance Publique - Hôpitaux de Paris